ICD-10 Diagnosis Code D69.1

Qualitative platelet defects

Diagnosis Code D69.1

ICD-10: D69.1
Short Description: Qualitative platelet defects
Long Description: Qualitative platelet defects
This is the 2018 version of the ICD-10-CM diagnosis code D69.1

Valid for Submission
The code D69.1 is valid for submission for HIPAA-covered transactions.

Code Classification
  • Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism (D50–D89)
    • Coagulation defects, purpura and other hemorrhagic conditions (D65-D69)
      • Purpura and other hemorrhagic conditions (D69)

Information for Medical Professionals

Convert to ICD-9 Additional informationCallout TooltipGeneral Equivalence Map
The ICD-10 and ICD-9 GEMs are used to facilitate linking between the diagnosis codes in ICD-9-CM and the new ICD-10-CM code set. The GEMs are the raw material from which providers, health information vendors and payers can derive specific applied mappings to meet their needs.

  • Acquired platelet disorder
  • Acquired platelet factor 3 disease
  • Acquired platelet function disorder
  • Acquired platelet function disorder
  • Acquired storage pool deficiency
  • Asplenia
  • Bernard Soulier syndrome
  • Congenital dysmegakaryopoietic thrombocytopenia, Paris Trousseau type
  • Congenital miosis
  • Cyclooxygenase deficiency
  • Decreased platelet destruction
  • Decreased platelet life span
  • Dense body defect
  • Exhausted platelets
  • Familial alpha>2< adrenergic receptor defect in platelets
  • Finding of platelet morphology
  • Giant platelet syndrome
  • Glanzmann's thrombasthenia
  • Glycoprotein Ia defect
  • Glycoprotein Ib defect
  • Gray platelet syndrome
  • Hereditary platelet function disorder
  • Hereditary thrombocytopenic disorder
  • Hereditary thrombocytopenic disorder
  • Increased platelet destruction
  • Ineffective thrombopoiesis
  • Inherited platelet disorder
  • Isolated collagen aggregation defect
  • Mediterranean macrothrombocytopenia
  • Megakaryocyte finding
  • Megakaryocytic thrombocytopenia
  • Mixed alpha granule and dense body deficiency
  • Montreal platelet syndrome
  • Platelet clumps
  • Platelet dense granule deficiency
  • Platelet disorder
  • Platelet dysfunction associated with uremia
  • Platelet dysfunction caused by aspirin
  • Platelet dysfunction caused by drugs
  • Platelet membrane defect
  • Platelet procoagulant activity deficiency
  • Platelet secretory disorder
  • Platelet sequestration
  • Platelet storage pool defect
  • Qualitative platelet disorder
  • Scott syndrome
  • Sensitized cell
  • Sensitized platelet
  • Storage pool disease of platelets
  • Thrombocytopathy, asplenia and miosis
  • Thromboxane generation defect
  • Thromboxane synthetase deficiency

Index of Diseases and Injuries
References found for the code D69.1 in the Index of Diseases and Injuries:

Information for Patients

Platelet Disorders

Also called: Thrombocyte disorders

Platelets are little pieces of blood cells. Platelets help wounds heal and prevent bleeding by forming blood clots. Your bone marrow makes platelets. Problems can result from having too few or too many platelets, or from platelets that do not work properly.

If your blood has a low number of platelets, it is called thrombocytopenia. This can put you at risk for mild to serious bleeding. If your blood has too many platelets, you may have a higher risk of blood clots. With other platelet disorders, the platelets do not work as they should. For example, in von Willebrand Disease, the platelets cannot stick together or cannot attach to blood vessel walls. This can cause excessive bleeding.

Treatment of platelet disorders depends on the cause.

NIH: National Heart, Lung, and Blood Institute

  • Bleeding time (Medical Encyclopedia)
  • Congenital platelet function defects (Medical Encyclopedia)
  • Glanzmann disease (Medical Encyclopedia)
  • Idiopathic thrombocytopenic purpura (ITP) (Medical Encyclopedia)
  • Partial thromboplastin time (PTT) (Medical Encyclopedia)
  • Platelet aggregation test (Medical Encyclopedia)
  • Primary thrombocythemia (Medical Encyclopedia)
  • Purpura (Medical Encyclopedia)
  • Thrombocytopenia (Medical Encyclopedia)
  • Thromobocytopenia - drug-induced (Medical Encyclopedia)

[Read More]

Glanzmann thrombasthenia Glanzmann thrombasthenia is a bleeding disorder that is characterized by prolonged or spontaneous bleeding starting from birth. People with Glanzmann thrombasthenia tend to bruise easily, have frequent nosebleeds (epistaxis), and may bleed from the gums. They may also develop red or purple spots on the skin caused by bleeding underneath the skin (petechiae) or swelling caused by bleeding within tissues (hematoma). Glanzmann thrombasthenia can also cause prolonged bleeding following injury, trauma, or surgery (including dental work). Women with this condition can have prolonged and sometimes abnormally heavy menstrual bleeding. Affected women also have an increased risk of excessive blood loss during pregnancy and childbirth.About a quarter of individuals with Glanzmann thrombasthenia have bleeding in the gastrointestinal tract, which often occurs later in life. Rarely, affected individuals have bleeding inside the skull (intracranial hemorrhage) or joints (hemarthrosis).The severity and frequency of the bleeding episodes in Glanzmann thrombasthenia can vary greatly among affected individuals, even in the same family. Spontaneous bleeding tends to become less frequent with age.
[Read More]

Gray platelet syndrome Gray platelet syndrome is a bleeding disorder associated with abnormal platelets, which are blood cell fragments involved in blood clotting. People with this condition tend to bruise easily and have an increased risk of nosebleeds (epistaxis). They may also experience abnormally heavy or extended bleeding following surgery, dental work, or minor trauma. Women with gray platelet syndrome often have irregular, heavy periods (menometrorrhagia). These bleeding problems are usually mild to moderate, but they have been life-threatening in a few affected individuals.A condition called myelofibrosis, which is a buildup of scar tissue (fibrosis) in the bone marrow, is another common feature of gray platelet syndrome. Bone marrow is the spongy tissue in the center of long bones that produces most of the blood cells the body needs, including platelets. The scarring associated with myelofibrosis damages bone marrow, preventing it from making enough blood cells. Other organs, particularly the spleen, start producing more blood cells to compensate; this process often leads to an enlarged spleen (splenomegaly).
[Read More]
Previous Code
Previous Code D69.0
Next Code
D69.2 Next Code